Cargando…

In vivo characterization of ischemic retina in diabetic retinopathy

OBJECTIVE: The aim of this article is to characterize pathomorphologic changes within particular layers of fluorescein angiographically ‘ischemic’ compared to ‘nonischemic’ retina in patients with diabetic retinopathy. METHODS: Cross-sectional images of ischemic retinal areas were obtained using Hei...

Descripción completa

Detalles Bibliográficos
Autores principales: Reznicek, Lukas, Kernt, Marcus, Haritoglou, Christos, Kampik, Anselm, Ulbig, Michael, Neubauer, Aljoscha S
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033002/
https://www.ncbi.nlm.nih.gov/pubmed/21311655
http://dx.doi.org/10.2147/OPTH.S13850
_version_ 1782197526670082048
author Reznicek, Lukas
Kernt, Marcus
Haritoglou, Christos
Kampik, Anselm
Ulbig, Michael
Neubauer, Aljoscha S
author_facet Reznicek, Lukas
Kernt, Marcus
Haritoglou, Christos
Kampik, Anselm
Ulbig, Michael
Neubauer, Aljoscha S
author_sort Reznicek, Lukas
collection PubMed
description OBJECTIVE: The aim of this article is to characterize pathomorphologic changes within particular layers of fluorescein angiographically ‘ischemic’ compared to ‘nonischemic’ retina in patients with diabetic retinopathy. METHODS: Cross-sectional images of ischemic retinal areas were obtained using Heidelberg Spectralis optical coherence tomography (OCT). Presumed retinal ischemia was defined as focal hypofluorescence in early or early and late phase fluorescein angiography. Pathomorphologic changes on OCT were evaluated and the thickness of retinal layers measured and compared with nonischemic retina at corresponding topographic locations in a matched-pairs design based on 22 eyes (mean age 64 ± 14). RESULTS: In all eyes, based on spectral domain-OCT cross-section images, the retina layers in ischemic retinal areas could be segmented. Total retinal thickness was significantly increased in ischemic compared to nonischemic areas (381 ± 94 μm versus 323 ± 89 μm, P = 0.005). Middle retinal layers (inner nuclear layer, outer plexiform layer, and outer nuclear layer) were significantly thickened in retinal ischemic areas (215 ± 82 μm versus 168 ± 62 μm, P = 0.002). The inner retinal layers (retinal nerve fiber layer, ganglion cell layer, and inner plexiform layer) showed a nonsignificant change (117 ± 53 μm versus 98 ± 30 μm), while the outer layers were slightly thinned (photoreceptors plus retinal pigment epithelium layer; 51 ± 9 μm versus 57 ± 8 μm, P = 0.02) in ischemic versus nonischemic retina. CONCLUSIONS: Ischemic diabetic retina seems to be thickened due to thickening of, in particular, middle retinal layers, which can be measured with high-resolution OCT.
format Text
id pubmed-3033002
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-30330022011-02-10 In vivo characterization of ischemic retina in diabetic retinopathy Reznicek, Lukas Kernt, Marcus Haritoglou, Christos Kampik, Anselm Ulbig, Michael Neubauer, Aljoscha S Clin Ophthalmol Original Research OBJECTIVE: The aim of this article is to characterize pathomorphologic changes within particular layers of fluorescein angiographically ‘ischemic’ compared to ‘nonischemic’ retina in patients with diabetic retinopathy. METHODS: Cross-sectional images of ischemic retinal areas were obtained using Heidelberg Spectralis optical coherence tomography (OCT). Presumed retinal ischemia was defined as focal hypofluorescence in early or early and late phase fluorescein angiography. Pathomorphologic changes on OCT were evaluated and the thickness of retinal layers measured and compared with nonischemic retina at corresponding topographic locations in a matched-pairs design based on 22 eyes (mean age 64 ± 14). RESULTS: In all eyes, based on spectral domain-OCT cross-section images, the retina layers in ischemic retinal areas could be segmented. Total retinal thickness was significantly increased in ischemic compared to nonischemic areas (381 ± 94 μm versus 323 ± 89 μm, P = 0.005). Middle retinal layers (inner nuclear layer, outer plexiform layer, and outer nuclear layer) were significantly thickened in retinal ischemic areas (215 ± 82 μm versus 168 ± 62 μm, P = 0.002). The inner retinal layers (retinal nerve fiber layer, ganglion cell layer, and inner plexiform layer) showed a nonsignificant change (117 ± 53 μm versus 98 ± 30 μm), while the outer layers were slightly thinned (photoreceptors plus retinal pigment epithelium layer; 51 ± 9 μm versus 57 ± 8 μm, P = 0.02) in ischemic versus nonischemic retina. CONCLUSIONS: Ischemic diabetic retina seems to be thickened due to thickening of, in particular, middle retinal layers, which can be measured with high-resolution OCT. Dove Medical Press 2011 2010-12-30 /pmc/articles/PMC3033002/ /pubmed/21311655 http://dx.doi.org/10.2147/OPTH.S13850 Text en © 2011 Reznicek et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Reznicek, Lukas
Kernt, Marcus
Haritoglou, Christos
Kampik, Anselm
Ulbig, Michael
Neubauer, Aljoscha S
In vivo characterization of ischemic retina in diabetic retinopathy
title In vivo characterization of ischemic retina in diabetic retinopathy
title_full In vivo characterization of ischemic retina in diabetic retinopathy
title_fullStr In vivo characterization of ischemic retina in diabetic retinopathy
title_full_unstemmed In vivo characterization of ischemic retina in diabetic retinopathy
title_short In vivo characterization of ischemic retina in diabetic retinopathy
title_sort in vivo characterization of ischemic retina in diabetic retinopathy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033002/
https://www.ncbi.nlm.nih.gov/pubmed/21311655
http://dx.doi.org/10.2147/OPTH.S13850
work_keys_str_mv AT rezniceklukas invivocharacterizationofischemicretinaindiabeticretinopathy
AT kerntmarcus invivocharacterizationofischemicretinaindiabeticretinopathy
AT haritoglouchristos invivocharacterizationofischemicretinaindiabeticretinopathy
AT kampikanselm invivocharacterizationofischemicretinaindiabeticretinopathy
AT ulbigmichael invivocharacterizationofischemicretinaindiabeticretinopathy
AT neubaueraljoschas invivocharacterizationofischemicretinaindiabeticretinopathy